Possible case for false-positive reaction in serum 5-S-cysteinyldopa levels in a patient with malignant melanoma by ingestion of Agaricus blazei Murrill extract

Journal of Dermatology

Volumn 37, Issue 8, 2010, Pages 773-775

  Konishi, Hiroshi ^a   Yamanaka, Keiichi ^a   Mizutani, Hitoshi ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGARICUS BLAZEI EXTRACT; BETA INTERFERON; CYSTEINYLDOPA;

CANCER SURGERY; FALSE POSITIVE RESULT; FINGER; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LETTER; MELANOMA; NONHUMAN; SKIN DEFECT;

AGARICUS; AGED; DIHYDROXYPHENYLALANINE; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INTERFERON-BETA; MELANOMA; NEOPLASM RECURRENCE, LOCAL; PLANT EXTRACTS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77954937812     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.00922.x     Document Type: Letter

References (10)

1. Firenzuoli F, Gori L, Lombardo G. The Medicinal Mushroom Agaricus blazei Murrill: Review of Literature and Pharmaco-Toxicological Problems. Evid Based Complement Alternat Med 2008 5 : 3 15.
2. Itoh H, Ito H, Hibasami H. Blazein of a new steroid isolated from Agaricus blazei Murrill (himematsutake) induces cell death and morphological change indicative of apoptotic chromatin condensation in human lung cancer LU99 and stomach cancer KATO III cells. Oncol Rep 2008 20 : 1359 1361.
3. Takimoto H, Wakita D, Kawaguchi K, Kumazawa Y. Potentiation of cytotoxic activity in naive and tumor-bearing mice by oral administration of hot-water extracts from Agaricus brazei fruiting bodies. Biol Pharm Bull 2004 27 : 404 406.
4. Gu Y, Fujimiya Y, Itokawa Y et al. Tumoricidal effects of beta-glucans: mechanisms include both antioxidant activity plus enhanced systemic and topical immunity. Nutr Cancer 2008 60 : 685 691.
5. Hanawa Y, Wakamatsu K, Ikeda S. Serum concentration of 5-S-cysteinyldopa in pediatric patients with giant pigmented nevi. J Dermatol 1996 23 : 16 21.
6. Wakamatsu K, Ito S. Seasonal variation in serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in healthy Japanese. Pigment Cell Res 1995 8 : 132 134.
7. Kikuchi K, Wakamatsu K, Tada Y et al. Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy. Clin Exp Dermatol 2008 33 : 750 753.
8. Asada Y, Arakawa S, Fujiwara S, Sato F, Kaneda K. High serum level of 5-S-cysteinyldopa in chronic renal failure does not always indicate melanoma progression. Br J Dermatol 2004 151 : 515 516.
9. Kiyohara S. Time course of serum 5-S-CD levels in long term followed up melanoma patients and its clinical evaluation. Jpn J Dermatol (in Japanese) 1996 106 : 261 269.
10. Yoshino K, Aoki M, Kawana S. A case of melanoma with elevation of 5-S-CD by Agaricus. Jpn J Clin Dermatol (Japanese) 2005 59 : 1013 1015.